Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study
Related Experiment Video
Updated: Aug 15, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Stacy D Fisher1, Kirk A Easley, E John Orav
1Midatlantic Cardiology Associates, Baltimore, MD, USA.
Insights
Cardiac abnormalities in children with HIV worsen in the first three years of life. This persistent left ventricular dysfunction and increased mass significantly raise the risk of mortality in pediatric HIV patients.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Cardiovascular Research
Background:
- Cardiac abnormalities are a significant cause of mortality in children with HIV.
- Understanding the progression of these abnormalities is crucial for improving outcomes.
Purpose of the Study:
- To investigate the longitudinal changes in left ventricular (LV) structure and function in vertically HIV-infected children.
- To determine the impact of these cardiac changes on all-cause mortality.
Main Methods:
- Longitudinal echocardiographic data were collected from 185 vertically HIV-infected children from infancy to 10 years of age.
- Age- or body surface area-adjusted z scores were calculated for 10 echocardiographic parameters.
- Mortality data were analyzed in relation to cardiac function and structure.
Main Results:
- Left ventricular (LV) function (fractional shortening) declined significantly in the first 3 years of life.
- Mild LV dysfunction was observed in 18% of children, with a 5-year mortality of 55.4%.
- Elevated LV mass persisted throughout follow-up, and children with severely elevated LV mass had a 75% 5-year mortality.
Conclusions:
- Progressive deterioration of LV structure and function occurs in the first 3 years of life in children with HIV.
- Persistent mild LV dysfunction and elevated LV mass are associated with increased all-cause mortality.
- Early identification and management of cardiac abnormalities are critical for improving survival in pediatric HIV.
Background:
Many HIV-infected children die with cardiac abnormalities. We sought to understand the course of these HIV-associated abnormalities and their impact on all-cause mortality.
Methods:
We describe longitudinal changes in left ventricular (LV) structure and function and mortality in 185 children vertically infected with HIV. Serial cardiac data were obtained from 0.1 to 10 years of age. Age- or body surface area-adjusted z scores were calculated for 10 echocardiographic outcomes.
Results:
Median age at first echocardiogram was 2 years (range 0.2-9.4 years); median follow-up was 3.6 years (range 0-6.3 years). The 5-year cumulative incidence of congestive heart failure was 12.3%. Mean fractional shortening z scores declined from -0.65 at 1 year of age to -1.47 at 3 years of age without further decline between 3 and 10 years of age. Among children with 2 echocardiograms performed in the first year of follow-up, mild LV dysfunction (fractional shortening of < -2 SD on both echocardiograms) was present in 29 (18%) of 158 children. For these 29 children, the 5-year mortality was 55.4%. Left ventricular mass z scores were elevated at 1 year (mean z score 0.68, P < .001) and remained elevated throughout follow-up. In the 8 children with LV mass z score of > 2 SD on both initial and follow-up echocardiograms, the 5-year mortality was 75%.
Conclusion:
In HIV-infected children, LV structure and function progressively deteriorated in the first 3 years of life, resulting in subsequent persistent mild LV dysfunction and increased LV mass. Chronic mild depression of LV function and elevated LV mass were associated with higher all-cause mortality.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests